Recombinant Bovine Type-1 angiotensin II receptor (AGTR1)

What is the molecular structure and basic characterization of bovine AGTR1?

Bovine AGTR1 is a seven-transmembrane domain G-protein coupled receptor (GPCR) with 359 amino acids and a predicted molecular weight of approximately 41.1 kDa . It belongs to the family of GPCRs that mediate the effects of Angiotensin II, the major bioactive peptide of the renin-angiotensin system . Human AGTR1 shares high sequence identity with mammalian orthologs (94% with mouse and 95% with rat) , suggesting strong evolutionary conservation of this receptor.

Unlike rodents which express two related genes (AGTR1A and AGTR1B), most species including bovines express a single AGTR1 gene . The receptor couples primarily to G proteins containing alpha q/11 subunits and activates multiple signal transduction pathways including:

• PLC-IP3-Ca2+ pathway

• PLC-DAG-PKC pathway

• MAPK pathway

• Jak/STAT signaling pathway

How is AGTR1 expression detected in bovine embryonic tissues?

Detection of AGTR1 in bovine embryonic tissues involves complementary approaches for both mRNA and protein analysis:

mRNA Expression Analysis:

• Total RNA extraction from bovine embryos using specialized kits (e.g., Absolutely RNA Nanoprep Kit)

• DNase I treatment to eliminate genomic DNA contamination

• Reverse transcription using temperature-optimized cDNA synthesis kits

• RT-PCR with primers designed to cross exon-exon boundaries (except for AGTR1, where primers target the coding region localized in one exon)

• β-Actin (ACTB) serves as a housekeeping gene control

• PCR conditions: 44 cycles for ACTB and 50 cycles for RAS components including AGTR1

Protein Localization:

• Immunofluorescence with specific antibodies against AGTR1

• Confocal microscopy analysis of stained embryos

• Western blotting for quantitative protein expression analysis

Research has demonstrated that AGTR1 protein is present in the plasma membrane of bovine embryonic cells, with additional localization in granular-like structures in the cytoplasm of trophectoderm cells and inner cell mass, suggesting potential receptor internalization .

What physiological roles does AGTR1 mediate in bovine systems?

AGTR1 mediates most of the physiological actions of Angiotensin II in bovine systems, similar to other mammals. These actions include:

• Vasoconstriction

• Aldosterone and vasopressin release

• Salt and water retention regulation

• Cell proliferation and migration

• Sympathetic nervous system stimulation

What are the signaling mechanisms of bovine AGTR1 in embryonic development?

Research on bovine pre-implantation embryos has revealed intriguing insights into AGTR1 signaling during early development:

• While AGTR1 and AGTR2 proteins are expressed in bovine embryos, there was no detectable expression of angiotensin II precursors (AGT, ACE) or renin (REN) under experimental conditions

• This suggests that embryos may be responsive to maternally-produced Angiotensin II rather than synthesizing it autonomously

• The renin-angiotensin system components (REN, AGT, ACE) are present in the maternal endometrium and vary cyclically, potentially providing developmental signals from mother to embryo

Experimental studies using receptor antagonists revealed:

• AGTR1 blockade with Olmesartan did not significantly affect embryo development parameters

• In contrast, AGTR2 blockade with PD123319 significantly increased the proportion of hatched embryos

These findings suggest a complex interplay between AGTR1 and AGTR2 in regulating embryo development, with AGTR2 potentially playing a restrictive role in embryo hatching, while AGTR1's precise developmental function requires further investigation .

How does AGTR1 inhibition affect cellular processes beyond cardiovascular regulation?

Recent research has uncovered important non-cardiovascular roles for AGTR1, particularly in cellular growth and senescence:

In hepatocellular carcinoma (HCC) cells, AGTR1 suppression:

• Dramatically restrained cellular growth

• Triggered G2-M cell phase arrest

• Increased expression of senescence markers p53, p-p53, p21, and p-p21

• Elevated percentages of SA-β-Gal-positive cells (a marker of cellular senescence)

• Worked through inactivation of ERK signaling

These findings suggest AGTR1 may function as a regulator of cellular senescence, with potential implications for development, aging, and cancer research . The connection between AGTR1 and senescence pathways could provide insights into its role in bovine embryonic development and tissue homeostasis beyond traditional cardiovascular functions.

What structural determinants influence ligand binding and selectivity in bovine AGTR1?

Molecular docking studies have provided insights into the structural basis of AGTR1 ligand binding:

• The 3D structure of AGTR1 (human model from PDB ID: 4YAY) reveals an asymmetric, monomeric structure with a specific binding pocket for antagonists

• Key binding pocket residues interact with established AGTR1 inhibitors including candesartan, losartan, and valsartan

• Virtual screening approaches have identified natural compounds with binding energies comparable to known AGTR1 inhibitors

Promising natural compounds identified through molecular docking include:

• ZINC85625504

• ZINC62001623

• ZINC70666587

• ZINC06624086

• ZINC95486187

These compounds interact with crucial AGTR1 residues based on docking simulations, suggesting potential as novel AGTR1 inhibitors for research applications .

What are the optimal techniques for studying AGTR1 expression in bovine embryos?

Based on published research protocols, the following methodologies represent current best practices for AGTR1 expression analysis in bovine embryos:

RNA Extraction and RT-PCR Protocol:

• Extract total RNA from bovine embryos using Absolutely RNA Nanoprep Kit with DNase I treatment

• Perform reverse transcription on RNA from approximately 20 embryos

• Use β-Actin (ACTB) as a housekeeping gene for normalization

• Design primers for AGTR1 within the coding region (located in one exon)

• Run PCR with 44 cycles for ACTB and 50 cycles for AGTR1

• Analyze PCR products on 1.8% agarose gel containing 0.5 μg/ml ethidium bromide

Protein Detection Protocol:

• Process embryos for immunofluorescence staining with AGTR1-specific antibodies

• Analyze receptor localization using confocal microscopy

• Confirm expression patterns across multiple embryonic stages from pre-implantation to hatched blastocyst

This combined approach provides comprehensive characterization of both mRNA expression and protein localization, enabling detailed analysis of spatial and temporal expression patterns during development.

How can researchers effectively investigate AGTR1 function in bovine embryonic development?

To assess AGTR1 function in bovine embryos, researchers can employ the following validated methodological approach:

Pharmacological Intervention Protocol:

• Culture bovine embryos in standard medium supplemented with:

  • Angiotensin II (agonist)

  • PD123319 (AGTR2 antagonist)

  • Olmesartan (AGTR1 antagonist)

  • Control medium (no supplements)

• Monitor embryo development parameters including:

  • Oocyte cleavage rates

  • Embryo expansion

  • Hatching rates

• Statistical analysis:

  • Compare treatment groups using appropriate statistical tests (e.g., one-way ANOVA with Bonferroni post hoc tests)

  • Consider p values < 0.05 as statistically significant

  • Present data as mean ± standard deviation

This approach has successfully demonstrated that AGTR2 blockade significantly improves embryo hatching, while AGTR1 blockade has limited effects on early embryonic development parameters .

What molecular docking approaches are effective for identifying bovine AGTR1 antagonists?

Researchers investigating bovine AGTR1 antagonists can employ the following molecular docking workflow:

Target Protein Preparation:

• Obtain 3D structure of AGTR1 (e.g., from RCSB PDB, ID: 4YAY)

• Remove water molecules, heteroatoms, and co-crystallized ligands

• Clean and process the protein structure before saving as a .pdb file

Virtual Screening Protocol:

• Prepare a library of compounds (e.g., natural compounds from ZINC database)

• Filter compounds using Lipinski and Veber Rules for drug-likeness

• Select compounds with molecular weights in appropriate range (300-500 Da)

• Set up grid parameters for docking (X=-16.087, Y=9.764, Z=41.290)

• Perform molecular docking using software like PyRx

• Analyze results based on binding energies compared to control compounds

• Visualize docked complexes using DS Visualizer or PyMol

Control Compounds for Comparison:

• ZD7 (co-crystal ligand)

• Candesartan

• Losartan

• Valsartan

This approach has successfully identified natural compounds with binding energies comparable to established AGTR1 inhibitors, providing valuable starting points for bovine-specific antagonist development .

How does AGTR1 contribute to maternal-embryonic communication in bovine reproduction?

Research suggests that AGTR1 may play a key role in maternal-embryonic signaling during early bovine development:

• Bovine embryos express AGTR1 and AGTR2 but not the precursors for Angiotensin II production (AGT, REN, ACE)

• This suggests embryos respond to maternally-produced Angiotensin II rather than producing it autonomously

• REN, AGT, and ACE are present in the endometrium and vary cyclically, potentially providing developmental signals from mother to embryo

• Angiotensin II could therefore function as a signaling molecule in maternal-embryonic communication

The differential expression of angiotensin receptors in embryos versus maternal tissues creates a signaling axis that may regulate key developmental processes including implantation and placentation. Further research using co-culture systems of embryos with endometrial cells could elucidate these communication mechanisms in greater detail.

What is the potential for developing bovine-specific AGTR1 antagonists for research applications?

Molecular docking studies have identified promising candidates for bovine-specific AGTR1 antagonists:

These compounds interact with crucial AGTR1 residues in molecular docking simulations, indicating their potential as AGTR1 inhibitors that could be developed into research tools . Development of bovine-specific antagonists would enable more precise investigation of AGTR1 functions in bovine systems without cross-reactivity with other angiotensin receptors.